containing 4-iodine-3-nitrobenzamide, physiologically compatible buffer and cyclodextrin, application of said composition for treatment of viral disease and cancer and method of treating viral disease and cancer.;EFFECT: composition possesses increased solubility in water solutions.;55 cl, 12 dwg, 10 ...
Cancer treatment has evolved rapidly in recent years, and there are many new options for targeted therapies that treat cancer with specific characteristics or help the immune system fight cancer. These therapies work more specifically against cancer than traditional chemotherapy, which kills rapidly growi...
This review concerns the effects on vision and the eye of medications prescribed at three phases of treatment for women with early-stage breast cancer (BC): (1) adjuvant cytotoxic chemotherapy, (2) adjuvant endocrine therapy, and (3) symptomatic relief. The most common side effects of cytotoxic...
Teon’s goal is working to restore anti-tumor immunity with once-daily, oral cancer medications allowing patients to spend time on what matters most.
Oncology patients undergoing radiation treatment and chemotherapy routinely use prescription and/or over-the counter medications either as part of pre-exis... Walter,Lemmo - 《International Journal of Cancer》 被引量: 5发表: 2014年 Disposal practices for unwanted residential medications in the United ...
7. Several biological mechanisms have been proposed to explain why diabetes may be associated with cancer, including inflammation, hyperglycemia, and hyperinsulinemia8,9. Furthermore, medications for diabetes may modify the association. Multiple epidemiologic studies have evaluated the association of ...
But the cancer drug shortages — which have jeopardized treatment for a wide range of adult and pediatric patients — are particularly problematic because getting timely treatment can mean the difference between life and death. “In some cases, there is not a good alter...
Hormonal therapy is the main recommended treatment for locally advanced and metastatic prostate cancer. Luteinizing hormone-releasing hormone (LHRH) agonis... RS Kirby,JM Fitzpatrick,N Clarke - 《Bju International》 被引量: 58发表: 2010年 New treatment paradigm for prostate cancer: abarelix initiation...
For example, something that’s worked well for years may not work anymore. You may need a whole new treatment plan. Let your doctor know how you’re really doing, and always tell them about any side effects that you have. Takeaways Finding the right medications to treat ulcerative colitis...
The development of therapeutic nanoparticles (TNPs) for cancer treatment is one of the fastest growing research areas in oncology. Accumulating evidence has shown many advantages of TNPs over freely delivered chemotherapeutic drugs, such as enhanced water solubility, tumor-specific accumulation, and antitu...